Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Expert Opinion on Investigational Drugs|March 7, 2008
Raltegravir: an integrase inhibitor for HIV-1Teresa H Evering, Martin Markowitz
Drugs of Today (Barcelona, Spain : 1998)|January 5, 2008
Raltegravir (MK-0518): an integrase inhibitor for the treatment of HIV-1Teresa Hope Evering, Martin Markowitz
Current Opinion in HIV and AIDS|April 27, 2018
4'-Ethynyl-2-fluoro-2'-deoxyadenosine, MK-8591: a novel HIV-1 reverse transcriptase translocation inhibitorMartin Markowitz, Stefan G Sarafianos
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2015
Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variantHiroshi Mohri, Nicole Prada, Martin Markowitz
Expert Opinion on Investigational Drugs|April 11, 2018
Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1Tristan D McPherson, Magdalena E Sobieszczyk, Martin Markowitz
The Journal of Allergy and Clinical Immunology|August 9, 2005
The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infectionSaurabh Mehandru, Klara Tenner-Racz, Paul Racz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2016
Brief Report: The Relationship Between Injection Drug Use Risk Behaviors and Markers of Immune ActivationSherry Deren, Charles M Cleland, Haekyung Lee, et al.
Pageof 12